Wayne A. Marasco
Harvard University
H-index: 67
North America-United States
Top articles of Wayne A. Marasco
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Anti-CD99 Antibody Therapy Triggers Macrophage-Dependent Ewing Cell Death In Vitro and Myeloid Cell Recruitment In Vivo | Antibodies | Allison F O’Neill Evelyn M Nguyen Evelyn D Maldonado Matthew R Chang Jiusong Sun | 2024/3/18 |
Affinity fine-tuning anti-CAIX CAR-T cells mitigate on-target off-tumor side effects | Molecular Cancer | Yufei Wang Alicia Buck Brandon Piel Luann Zerefa Nithyassree Murugan | 2024/3/16 |
Humanized cc chemokine receptor 4 (ccr4) antibodies and methods of use thereof | 2023/8/15 | ||
Immune-restoring CAR-T cells display antitumor activity and reverse immunosuppressive TME in a humanized ccRCC mouse model | Iscience | Yufei Wang Jae-Won Cho Gabriella Kastrunes Alicia Buck Cecile Razimbaud | 2024/2/16 |
Looking to the future of antibody genetics: resolving the roles of immunoglobulin diversity in gene regulation, function, and immunity | Genes & Immunity | Corey T Watson Oscar L Rodriguez Eric Engelbrecht Yana Safonova Wayne A Marasco | 2024/2 |
Fine-tuning affinity/avidity of anti-CAIX CAR T cells to mitigate on-target off-tumor toxicity in clear cell renal cell carcinoma | Cancer Research | Stephen Hsien-Chi Yuan Yufei Wang Rabia Abbas Peterson Mathenge Charles Chien | 2024/3/22 |
Evolution of cell therapy for renal cell carcinoma | Yufei Wang Eloah Rabello Suarez Gabriella Kastrunes Najla Santos Pacheco de Campos Rabia Abbas | 2024/12 | |
Establishing orthotopic renal cell carcinoma xenograft in PBMC-humanized immunodeficient NSG-MHC I/II double knock-out mice | Cancer Research | Wonyoung Kang Yufei Wang Yasmin N Laimon Oanh Pham Ben Matran | 2024/3/22 |
Clinical course and native antibody development after COVID-19 infection in 50 pediatric oncology patients. | Maeve Smart Olivia Puopolo Matthew R Chang Hanzhong Ke Wayne A Marasco | 2023/6/1 | |
Coronavirus antibodies and methods of use thereof | 2023/11/23 | ||
Antibodies against pd-l1 and methods of use thereof | 2023/4/27 | ||
Glucocorticoid-induced tumor necrosis factor receptor (GITR) antibodies and methods of use thereof | Gastroenterology | Gongxian Liao Cynthia Detre Scott B Berger Pablo Engel Rene de Waal Malefyt | 2012/3/1 |
fine-tuned CAIX targeted CAR-T cells exhibit superior efficacy and mitigate on-target off-tumor side effects | Cancer Research | Yufei Wang Alicia Buck Gabriella Kastrunes Rabia Abbas Michael Lynch | 2023/4/4 |
442 CAIX targeted CAR-T cells exhibited antitumor efficacy on renal cell carcinoma (RCC) patient derived organotypic tumor spheroids (PDOTS) | Yufei Wang Alicia Buck Brandon Piel Luann Zerefa Andras-Gabor Miklosi | 2023/11/1 | |
Correction to: The variable conversion of neutralizing anti-SARS-CoV-2 single-chain antibodies to IgG provides insight into RBD epitope accessibility | Protein Engineering, Design and Selection | Rebecca Johnson Kamkaew Nadia Storm Anna Honko Quan Zhu Anthony Griffiths | 2023 |
ANTIBODIES TO PD-1 AND METHODS OF USE THEREOF | 2023/10/25 | ||
The variable conversion of neutralizing anti-SARS-CoV-2 single-chain antibodies to IgG provides insight into RBD epitope accessibility | Protein Engineering, Design and Selection | Matthew R Chang Hanzhong Ke Laura Losada Miguéns Christian Coherd Katrina Nguyen | 2023 |
Genetic variation in the immunoglobulin heavy chain locus shapes the human antibody repertoire | Nature communications | Oscar L Rodriguez Yana Safonova Catherine A Silver Kaitlyn Shields William S Gibson | 2023/7/21 |
Methods for depleting or inhibiting the migration of regulatory T-cells in early or late stages of cancer | 2022/3/1 | ||
Immunogenetic restriction on elicitation of antibodies | 2022/5/5 |
